These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18382139)

  • 21. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.
    Su H; Morrison RP; Watkins NG; Caldwell HD
    J Exp Med; 1990 Jul; 172(1):203-12. PubMed ID: 1694217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.
    Kari L; Whitmire WM; Olivares-Zavaleta N; Goheen MM; Taylor LD; Carlson JH; Sturdevant GL; Lu C; Bakios LE; Randall LB; Parnell MJ; Zhong G; Caldwell HD
    J Exp Med; 2011 Oct; 208(11):2217-23. PubMed ID: 21987657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary approaches to designing and evaluating vaccines against Chlamydia.
    Igietseme JU; Eko FO; Black CM
    Expert Rev Vaccines; 2003 Feb; 2(1):129-46. PubMed ID: 12901604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Considerations for the rational design of a Chlamydia vaccine.
    Liang S; Bulir D; Kaushic C; Mahony J
    Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for Chlamydia infections of the female genital tract.
    Hafner LM; McNeilly C
    Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of molecular tools in the control of blinding trachoma.
    Mabey D; Solomon AW
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):11-7. PubMed ID: 14692675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
    Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
    Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trachoma: an overview.
    Burton MJ
    Br Med Bull; 2007; 84():99-116. PubMed ID: 18175788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia vaccine candidates and tools for chlamydial antigen discovery.
    Rockey DD; Wang J; Lei L; Zhong G
    Expert Rev Vaccines; 2009 Oct; 8(10):1365-77. PubMed ID: 19803759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
    Yu H; Karunakaran KP; Jiang X; Brunham RC
    Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global elimination of blinding trachoma: progress and promise.
    Kumaresan JA; Mecaskey JW
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):24-8. PubMed ID: 14692677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trachoma.
    Taylor HR
    Int Ophthalmol; 1990 May; 14(3):201-4. PubMed ID: 2188922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia vaccines: recent developments and the role of adjuvants in future formulations.
    Igietseme JU; Eko FO; Black CM
    Expert Rev Vaccines; 2011 Nov; 10(11):1585-96. PubMed ID: 22043957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydial eye infections: Current perspectives.
    Satpathy G; Behera HS; Ahmed NH
    Indian J Ophthalmol; 2017 Feb; 65(2):97-102. PubMed ID: 28345563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis.
    Pickering H; Burr SE; Derrick T; Makalo P; Joof H; Hayward RD; Holland MJ
    Parasit Vectors; 2017 Mar; 10(1):143. PubMed ID: 28288672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
    Jiang P; Cai Y; Chen J; Ye X; Mao S; Zhu S; Xue X; Chen S; Zhang L
    Vaccine; 2017 May; 35(23):3096-3103. PubMed ID: 28456528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
    Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
    J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.
    Dean D; Kandel RP; Adhikari HK; Hessel T
    PLoS Med; 2008 Jan; 5(1):e14. PubMed ID: 18177205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical review of the SAFE strategy for the prevention of blinding trachoma.
    Kuper H; Solomon AW; Buchan J; Zondervan M; Foster A; Mabey D
    Lancet Infect Dis; 2003 Jun; 3(6):372-81. PubMed ID: 12781509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.